bpc 157 fda ind or nda An advisory panel voted on BPC-157 today., That does not mean BPC-157 was FDA approved., The panel recommended that BPC-157 be considered for addition to a list of substances that may be used by FDA's Overreach on Compounded Peptides
FDA's Overreach on Compounded Peptides Getting a drug approved is not as simple as the FDA said yes. Before a medicine reaches patients, it has to move through years of testing, evidence generation, regulatory review, and risk benefit TLDR; no. BPC 157 is a peptide that is not approved by the FDA, but it seems like our good friends over at the supplement industry marketing team have gotten their hands on biopharma #regulatoryaffairs #lifesciences #bostonbiodevelopment #fdaapproval Boston Biodevelopment LLC
Pay in 4 interest-free payments of $5.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
